Asclepius Meditec

For over a decade, the Asclepius team has been dedicated to advancing product development and medical research related to hydrogen oxygen devices. To date, the company has secured over 500 global invention patents and published 97 academic papers, 86 of which are indexed in the SCI database. Asclepius remains the only hydrogen therapy machine manufacturer worldwide capable of producing a Class III medical-grade device approved for human inhalation. Our hydrogen–oxygen nebulizer and other hydrogen therapy devices provide a solution that is safe, effective, non-toxic, compact, and exceptionally quiet. The company was granted two medical device licenses by the China National Medical Products Administration in 2020 and 2023, and is on track to obtain EU CE certification in 2026.

Professor Zhong Nanshan, Director of China’s National Center for Respiratory Diseases and Academician of the Chinese Academy of Engineering, commented:“Using water and targeted nutrition to enhance cellular ATP production can improve physical resilience, prevent illness, assist in treatment, and reduce the need for invasive procedures. This is a groundbreaking innovation with the potential to reshape the future of life sciences.”